Knowledge Sourcing Intelligence (KSI)
Home/Healthcare/Diagnostics/Global Blood Transfusion Diagnostics Market

Global Blood Transfusion Diagnostics Market - Strategic Insights and Forecasts (2025-2030)

Market Size, Share & Forecasts By Type (Instruments, Kits & Reagents), By Technology (ELISA, Western Blotting, Nucleic Acid Amplification, Others), By End-User (Hospitals & Clinics, Diagnostic Labs, Blood Banks), and Geography

Market Size in 2025
USD 4.48 billion
Market Size in 2030
USD 6.77 billion
CAGR 2025-2030
8.59%
Study Period
2020-2030
Single User License
$3,950
Formats
PDF, Excel, PPT, Dashboard
Pages
144
Data update
2026 refresh included
Report OverviewSegmentationTable of ContentsCustomize Report

The Blood Transfusion Diagnostics market will grow at a CAGR of 8.59% from USD 4.48 billion in 2025 to USD 6.77 billion in 2030.

Global Blood Transfusion Diagnostics Market - Strategic Insights and Forecasts (2025-2030) market growth projection from $4.48B in 2025 to $6.77B by 2030 at a CAGR of 8.59%.
Global Blood Transfusion Diagnostics Market - Strategic Insights and Forecasts (2025-2030) market growth projection from $4.48B in 2025 to $6.77B by 2030 at a CAGR of 8.59%.

Highlights:

  1. 1
    The Blood Transfusion Diagnostics Market is experiencing robust growth due to rising demand.
  2. 2
    Advanced molecular platforms are enhancing accuracy in detecting transfusion-transmissible infections.
  3. 3
    North America is leading the market with high acceptance and developed infrastructure.
  4. 4
    Chronic disorders like anemia and CKD are driving increased need for blood transfusions.

Blood transfusion diagnostics refers to testing conducted on blood and blood components before transfusion to patients. To avoid adverse reactions or infection transmission, each blood unit must be checked for blood group type and disease screening. It is an essential component of transfusion treatment since it offers vital information to healthcare practitioners and validates the compatibility of donor and recipient blood samples. Red blood cells are the most frequently transfused blood products. Molecular blood group diagnosis is one of the transfusion diagnostics. For patients with antibodies against clinically relevant, uncommon, or weak antigens, molecular blood group diagnosis allows for safer blood storage and on-demand supplies.

Developing and underdeveloped countries lack proper blood banks, medical equipment required for blood transfusion, adequate conditions for blood storage, and a limited supply of blood in response to high demand. Hospitals lack the necessary amenities to deliver hygienic and safe transfusions. Thus, the escalating burden of chronic disorders and the rising need for donor screening are boosting the market’s growth. Furthermore, the rising need for transfusions because of trauma, car accidents, and surgical procedures is favorably influencing the market.

The emergence of advanced molecular platforms by market leaders accelerates the transition from manual testing and equipment to semi-automated and fully automated devices. These automated systems have been critical in detecting transfusion transmissible infections (TTIs) in blood samples and can accurately remove human error throughout the transfusion procedure.

During the forecast period, North America is expected to be the largest regional market for the global blood transfusion diagnostics market. This dominance can be attributed to increased acceptance of the blood transfusion procedure, increased public awareness regarding blood donations, and developed healthcare infrastructure. According to data released by the National Center for Biotechnology Information, over 15 million blood units are transfused in the United States each year, with an estimated 85 million units transfused globally.

Blood Transfusion Diagnostics Market Growth Drivers:

  • Blood and blood components are in high demand is anticipate in the market growth

The rising prevalence of blood-related conditions such as hemophilia, cancer, thrombocytopenia, and others, as well as chronic kidney disease (CKD), has increased the demand for blood transfusions. According to World Kidney Day estimates, about 850 million individuals worldwide will be suffering from kidney diseases in 2020. In addition, one out of every ten individuals has chronic kidney disease (CKD), which is predicted to become the sixth leading cause of death by the end of 2040. Furthermore, the growing number of patients suffering from anemia necessitates red blood cell transfusion for treatment, which is further driving up the demand for blood transfusion diagnostics. The World Health Organization (WHO) estimates that anaemia affects around 1.62 billion people worldwide. This, together with increased awareness regarding blood safety from infectious diseases through various initiatives in developed and developing nations, is driving up demand for blood screening tests and other diagnostic instruments.

Blood Transfusion Diagnostics Market Restraints:

  • The high cost of instruments and a lack of infrastructure

Despite the rising prevalence of chronic blood disorders and increased demand for blood transfusions, several issues are impeding the market’s growth. One of the causes is a lack of investment in healthcare infrastructure and strict government policies, particularly in developing nations when compared to developed countries. Furthermore, the high cost of tests, instruments, and reagents, along with a shortage of qualified professionals to handle automated diagnostic solutions, is one of the factors restraining the growth of the blood transfusion diagnostics market during the forecast period.

Blood Transfusion Diagnostics Market Competitive Insights:

Officials from the State Blood Transfusion Council (SBTC) reported in September 2021 that supplies in Maharashtra blood banks would barely last a week. This drop was attributed to a decrease in blood donation camps, reduced donor footfall owing to the pandemic, and the closure of offices and institutions in the state.

SEGMENT SHARE DISTRIBUTION (ILLUSTRATIVE)
Market Share Breakdown — By Technology
Unlock Exact Segment Splits →
ELISA
Western Blotting
Nucleic Acid Amplification
Others
Bar lengths are illustrative. The full report gives historical and forecast revenue for each segment.
HISTORICAL & FORECAST DATA TABLE (ILLUSTRATIVE)
By Type — Revenue by Year (2025–2030)
Segment202520262027202820292030CAGR (%)
Instruments
Kits & Reagents
Total Market SizeUSD 4.48 billionUSD 6.77 billion8.59%
Unlock Full Historical & Forecast Excel Databook (2025–2030)
Download Sample Excel →

The American Red Cross started a new nationwide initiative in September 2021 to reach out to more black blood donors to aid patients with sickle cell disease and improve health outcomes. Blood donations from individuals of the same race or ethnicity as well as blood type are the most reliable option to treat sickle cell patients.

Blood Transfusion Diagnostics Market Key Developments:

  • March 2023- MedGenome Labs has introduced the FSHD1 genetic screening test, the Optical Genome Mapping Test (OGM), to assess early-stage genetic changes in patients with Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1). This advanced diagnostic tool uses advanced technology to provide a comprehensive and accurate assessment of genetic changes, detecting both large-scale insertions and duplications, as well as subtle DNA changes.

  • May 2021- F. Hoffmann-La Roche Ltd and Bio-Rad Laboratories, Inc. have partnered to offer customers access to Bio-Rad's InteliQ products and Unity QC data management solutions. The partnership aims to enhance workflow efficiency and improve analytical performance in laboratories. Bio-Rad's InteliQ products, including barcoded quality control tubes, are part of the alliance.

List of Top Blood Transfusion Diagnostics Companies:

  • Quotient Ltd.

  • BAG Healthcare

  • Abbott

  • Immucor

  • Diasorin SPA

Blood Transfusion Diagnostics Market Scope

Report Metric Details
Total Market Size in 2025 USD 4.48 billion
Total Market Size in 2030 USD 6.77 billion
Forecast Unit Billion
Growth Rate 8.59%
Study Period 2020 to 2030
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2030
Segmentation Type, Technology, End-User, Geography
Companies
  • Diasorin SPA
  • Bio-Rad Laboratories Inc.
  • Grifols S.A.
  • F. Hoffmann La Roche Ltd.
  • Beckman Coulter Inc.
Customization Scope 15% Free Customization included with purchase — Request Custom Breakdown →
Sample & Data Access PDF Sample, Excel Databook & Analyst Briefing — Download Free Sample →

Need country-level data or a custom regional split for your target market?Request Regional Data →

Market Segmentation

By Type
  • Instruments
  • Kits & Reagents
By Technology
  • ELISA
  • Western Blotting
  • Nucleic Acid Amplification
  • Others
By End-User
  • Hospitals & Clinics
  • Diagnostic Labs
  • Blood Banks
By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • France
  • Germany
  • Italy
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • Taiwan
  • Indonesia

Table of Contents

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. CXO Perspective

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET, BY TYPE

5.1. Introduction

5.2. Instruments

5.2.1. Market Opportunities and Trends

5.2.2. Growth Prospects

5.2.3. Geographic Lucrativeness

5.3. Kits & Reagents

5.3.1. Market Opportunities and Trends

5.3.2. Growth Prospects

5.3.3. Geographic Lucrativeness

6. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET, BY TECHNOLOGY

6.1. Introduction

6.2. ELISA

6.2.1. Market Opportunities and Trends

6.2.2. Growth Prospects

6.2.3. Geographic Lucrativeness

6.3. Western Blotting

6.3.1. Market Opportunities and Trends

6.3.2. Growth Prospects

6.3.3. Geographic Lucrativeness

6.4. Nucleic Acid Amplification

6.4.1. Market Opportunities and Trends

6.4.2. Growth Prospects

6.4.3. Geographic Lucrativeness

6.5. Others

6.5.1. Market Opportunities and Trends

6.5.2. Growth Prospects

6.5.3. Geographic Lucrativeness

7. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET, BY END-USER

7.1. Introduction

7.2. Hospitals & Clinics

7.2.1. Market Opportunities and Trends

7.2.2. Growth Prospects

7.2.3. Geographic Lucrativeness

7.3. Diagnostic Labs

7.3.1. Market Opportunities and Trends

7.3.2. Growth Prospects

7.3.3. Geographic Lucrativeness

7.4. Blood Banks

7.4.1. Market Opportunities and Trends

7.4.2. Growth Prospects

7.4.3. Geographic Lucrativeness

8. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET, BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Type

8.2.2. By Technology

8.2.3. By End-User

8.2.4. By Country

8.2.4.1. United States

8.2.4.1.1. Market Opportunities and Trends

8.2.4.1.2. Growth Prospects

8.2.4.2. Canada

8.2.4.2.1. Market Opportunities and Trends

8.2.4.2.2. Growth Prospects

8.2.4.3. Mexico

8.2.4.3.1. Market Opportunities and Trends

8.2.4.3.2. Growth Prospects

8.3. South America

8.3.1. By Type

8.3.2. By Technology

8.3.3. By End-User

8.3.4. By Country 

8.3.4.1. Brazil

8.3.4.1.1. Market Opportunities and Trends

8.3.4.1.2. Growth Prospects

8.3.4.2. Argentina

8.3.4.2.1. Market Opportunities and Trends

8.3.4.2.2. Growth Prospects

8.3.4.3. Others

8.3.4.3.1. Market Opportunities and Trends

8.3.4.3.2. Growth Prospects

8.4. Europe

8.4.1. By Type

8.4.2. By Technology

8.4.3. By End-User

8.4.4. By Country

8.4.4.1. United Kingdom

8.4.4.1.1. Market Opportunities and Trends

8.4.4.1.2. Growth Prospects

8.4.4.2. Germany

8.4.4.2.1. Market Opportunities and Trends

8.4.4.2.2. Growth Prospects

8.4.4.3. France

8.4.4.3.1. Market Opportunities and Trends

8.4.4.3.2. Growth Prospects

8.4.4.4. Italy

8.4.4.4.1. Market Opportunities and Trends

8.4.4.4.2. Growth Prospects

8.4.4.5. Spain

8.4.4.5.1. Market Opportunities and Trends

8.4.4.5.2. Growth Prospects

8.4.4.6. Others

8.4.4.6.1. Market Opportunities and Trends

8.4.4.6.2. Growth Prospects

8.5. Middle East and Africa

8.5.1. By Type

8.5.2. By Technology

8.5.3. By End-User

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.1.1. Market Opportunities and Trends

8.5.4.1.2. Growth Prospects

8.5.4.2. UAE

8.5.4.2.1. Market Opportunities and Trends

8.5.4.2.2. Growth Prospects

8.5.4.3. Others

8.5.4.3.1. Market Opportunities and Trends

8.5.4.3.2. Growth Prospects

8.6. Asia Pacific

8.6.1. By Type

8.6.2. By Technology

8.6.3. By End-User

8.6.4. By Country

8.6.4.1. Japan

8.6.4.1.1. Market Opportunities and Trends

8.6.4.1.2. Growth Prospects

8.6.4.2. China

8.6.4.2.1. Market Opportunities and Trends

8.6.4.2.2. Growth Prospects

8.6.4.3. India

8.6.4.3.1. Market Opportunities and Trends

8.6.4.3.2. Growth Prospects

8.6.4.4. South Korea

8.6.4.4.1. Market Opportunities and Trends

8.6.4.4.2. Growth Prospects

8.6.4.5. Taiwan

8.6.4.5.1. Market Opportunities and Trends

8.6.4.5.2. Growth Prospects

8.6.4.6. Thailand

8.6.4.6.1. Market Opportunities and Trends

8.6.4.6.2. Growth Prospects

8.6.4.7. Indonesia

8.6.4.7.1. Market Opportunities and Trends

8.6.4.7.2. Growth Prospects

8.6.4.8. Others

8.6.4.8.1. Market Opportunities and Trends

8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Quotient Ltd.

10.2. BAG Healthcare

10.3. Abbott

10.4. Immucor

10.5. Diasorin SPA

10.6. Bio-Rad Laboratories Inc.

10.7. Grifols S.A.

10.8. F. Hoffmann La Roche Ltd.

10.9. Beckman Coulter Inc.

10.10. DIAGAST

Trusted by industry leaders
AmazonABBFujifilmHitachiMcKinseyAmazonABBFujifilmHitachiMcKinsey
Report IDKSI061611612
Last updated
Pages144

Frequently asked questions

What is the projected growth trajectory for the Global Blood Transfusion Diagnostics Market from 2025 to 2030?

The Global Blood Transfusion Diagnostics Market is projected to grow significantly, expanding from USD 4.48 billion in 2025 to USD 6.77 billion by 2030. This growth is anticipated at a robust Compound Annual Growth Rate (CAGR) of 8.59% over the forecast period.

What are the primary drivers fueling the growth of the Blood Transfusion Diagnostics Market?

The Global Blood Transfusion Diagnostics Market's growth is primarily driven by the escalating burden of chronic disorders like anemia and CKD, which increase the need for blood transfusions. Additionally, the rising incidence of trauma, car accidents, and surgical procedures, along with the critical need for comprehensive donor screening, are significant growth factors.

Which geographic region is expected to dominate the Global Blood Transfusion Diagnostics Market during the forecast period?

North America is projected to be the largest regional market for global blood transfusion diagnostics from 2025 to 2030. This dominance is attributed to increased public awareness regarding blood donations, high acceptance of blood transfusion procedures, and a well-developed healthcare infrastructure.

What key technological trends are influencing the Blood Transfusion Diagnostics Market?

The Global Blood Transfusion Diagnostics Market is significantly shaped by the emergence of advanced molecular platforms, which are accelerating the shift from manual testing to semi-automated and fully automated devices. These automated systems are critical for accurately detecting transfusion-transmissible infections (TTIs) and minimizing human error during the transfusion procedure.

How does the 'Global Blood Transfusion Diagnostics Market Report' segment its analysis?

The report provides a comprehensive analysis segmented by Type (Instruments, Kits & Reagents), by Technology (ELISA, Western Blotting, Nucleic Acid Amplification, Others), by End-User (Hospitals And Clinics, Diagnostic Labs, Blood Banks), and by Geography. This detailed breakdown offers a granular view of market opportunities and trends.

What opportunities exist for the Blood Transfusion Diagnostics Market in developing economies?

Despite challenges like limited blood supply and inadequate infrastructure, developing and underdeveloped countries present significant opportunities for market growth. Addressing the lack of proper blood banks, medical equipment, and suitable storage conditions can expand access to essential blood transfusion diagnostics and services.

Cite this report

Knowledge Sourcing Intelligence. (Apr 2026). Global Blood Transfusion Diagnostics Market - Strategic Insights and Forecasts (2025-2030). https://www.knowledge-sourcing.com/report/global-blood-transfusion-diagnostics-market

Get notified when this report is updated